Urinary Tract Infection Treatment Market to Incur Value Growth at 2.2% CAGR By 2027
Global Urinary Tract Infection (UTI) Treatment Market
Urinary Tract Infection (UTI) is caused when bacteria enters the urethra and infects the urinary bladder, causing severe health issues. UTI infections are more common in females than in males, with several biologic factors considered as the major causes. Antibiotics are usually the first line of treatment prescribed by doctors for urinary tract infections. The sites where the microbes usually manifest are classified as cystitis (bladder), urethritis (urethra), prostatitis (prostate), and pyelonephritis (kidney). Painful urination, frequent and persistent urge to urinate, and excessive and involuntary passing of urine at night are among the common symptoms of UTI. Hospitalized patients using urinary catheters are often at a higher risk of developing this condition.
Get Sample PDF Brochure with Impact of COVID19: https://www.coherentmarketinsights.com/insight/request-sample/1178
Increasing prevalence of urinary infections expected to boost the UTI treatment market growth
Rise in chronic kidney diseases and increasing use of urinary catheters have led to a rampant increase in the number of UTI cases worldwide, which is expected to accelerate the global urinary tract infection treatment market growth. According to the Centers of Disease Control and Prevention (CDC), UTIs are reckoned as the most common bacterial infections globally, which are said to affect over 150 million people every year. Furthermore, about 10 of every 25 women and 3 of every 25 men are estimated to have the common symptoms of at least one UTI during their lifetimes. In a study conducted by Sultan Qaboos University Medical Journal in 2013, it was revealed that around 50% to 60% of women are diagnosed with UTI each year. UTI patients, especially who are diabetic, have a higher frequency of UTIs, due to the presence of long-term complications of diabetes, such as neuropathy. According to the American Diabetes Association, around 9.4% of the U.S. population with diabetes was diagnosed with UTI in 2017.
Approval of combination products for improving the indications of existing drugs and combatting multi-drug-resistant bacteria are some of the key factors positively affecting the global market growth. For instance, in 2015, Avycaz (ceftazidime and avibactam), in combination with metronidazole, which has limited or no alternative treatment options, was approved by the Food & Drug Administration (FDA) for complicated abdominal and urinary tract infections.
Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!
Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://bit.ly/3vwItDJ
Global Urinary Tract Infection (UTI) Treatment Market Taxonomy
On the basis of drug type:
- Nitrofurans
- Sulphonamides
- Quinolones
- Azoles and Amphotericin B
- Aminoglycoside antibiotics
- Tetracycline
- Others
Based on indication:
- Complicated UTI
- Uncomplicated UTI
- Recurring Complicated UTI
By distribution channel:
- Hospital Pharmacies
- e-Pharmacies
- Retail Pharmacies
View Press Release For More Information @ https://www.coherentmarketinsights.com/press-release/urinary-tract-infection-treatment-market-3424
Rising catheter associated urinary infections is expected to fuel growth of the urinary tract infection treatment market in North America
Regional segmentation of the urinary tract infection treatment market comprises North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to dominate the global market owing to higher prevalence of neurogenic bladder infections, catheter associated infections and increased research and development spending on new drugs. According to the Agency of Healthcare Research and Quality — one of 12 Agencies within the United States Department of Health and Human Services —2016, around 250,000 catheter-associated urinary tract infections are reported in hospitals each year, costing about US $ 250 million in the U.S. Moreover, in 2016, the Agency for Healthcare Research and Quality (AHRQ), along with the Health Research and Educational Trust launched a nationwide effort to implement the Comprehensive Unit-based Safety Program (CUSP) to reduce catheter-associated UTIs in the U.S. hospitals. Asia Pacific is expected to exhibit fastest growth in the market owing to increasing prevalence of diabetes, and government initiatives to invest in research and development in emerging economies such as China and India. According to the Asian Diabetes Prevention Initiative, 2013, an estimated 113.9 million adults in China, and 65.1 million adults in India have diabetes. By 2030, China and India combined will have almost half a billion diabetics.
Global Urinary Tract Infection (UTI) Treatment Market – Competitive Landscape
The key players operating in the global urinary tract infection treatment market include Cipla Ltd., Johnson & Johnson, Bayer AG, Pfizer Inc., GlaxoSmithKline, Boehringer Ingelheim, F. Hoffmann-La Roche Ltd., Novartis AG AstraZeneca Plc, and Roche Ltd. The principal strategies adopted by these players include acquisitions and collaborations. For instance, in 2016, GlaxoSmithKline and Fimbrion Therapeutics, Inc., entered into a collaboration deal, which was focused on preclinical development of mannose-containing small molecule compounds, called mannosides, for the treatment and prevention of urinary tract infections.
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Disease Indication
- Market Snippet, By Distribution Channel
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Developments
- Regulatory Scenario
- PEST Analysis
- COVID-19 Impact Analysis
- Market Dynamics
- Global Urinary Tract Infection Treatment Market, By Drug Type, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Penicillin & Combinations
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Amoxicillin
- Amoxicillin+ Clavulanate
- Potassium”
- Others
- Quinolones
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Ciprofloxacin
- Levofloxacin
- Nalidixic acid
- Norfloxacin
- Others
- Cephalosporin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Ceftriaxone
- Cefuroxime
- Cefixime
- Cephalexin
- Aminoglycoside Antibiotics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Segment Trends
- Amikacin
- Gentamicin
- “Sulphonamides (Sulfamethoxazole +
- Trimethoprim)”
- Azoles and Amphotericin B
- Tetracycline (Doxycycline)
- Nitrofurans (Nitrofurantoin)
- Other
- Introduction
- Global Urinary Tract Infection Treatment Market, By Disease Indication, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Complicated UTI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Recurring Complicated UTI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Uncomplicated UTI
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Neurogenic Bladder Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Urinary Tract Infection Treatment Market, By Distribution Channel, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Urinary Tract Infection Treatment Market, By Regions, 2019 – 2027 (US$ Mn)
- Introduction
- Market Share Analysis, 2019 and 2027 (%)
- Y-o-Y Growth Analysis, 2017–2027
- Segment Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
- Competitive Landscape
- Company Profiles
- Section
- References
- Research Methodology
- About us and Sales Contact
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
Editor Details
-
Company:
- CDN Newswire
